Biological modification of arrhythmogenic substrates by cell-free therapeutics
YN Lin, R Miguel-dos-Santos, E Cingolani - Heart, Lung and Circulation, 2023 - Elsevier
Ventricular arrhythmias (VAs) represent a major cause of sudden cardiac death and afflict
patients with heart failure from both ischaemic and non-ischaemic origins, and inherited …
patients with heart failure from both ischaemic and non-ischaemic origins, and inherited …
Indirect comparison of cryoablation and radiofrequency ablation as initial therapy for symptomatic paroxysmal atrial fibrillation: A systematic review and network meta …
Y Mao, L Ai, Y Cai, Q Huang, F Yu, J Chen, P Huang… - Cardiology, 2023 - karger.com
Introduction: Data on first-line ablation treatment for patients with symptomatic atrial
fibrillation (AF) are scarce. This study indirectly compared the efficacy and safety of …
fibrillation (AF) are scarce. This study indirectly compared the efficacy and safety of …
Mortality associated with antiarrhythmic medication for atrial fibrillation among patients with left ventricular hypertrophy
AC Agdamag, A Westanmo, A Gravely… - Pacing and Clinical …, 2023 - Wiley Online Library
Background Atrial fibrillation (AF) guidelines recommend amiodarone as the preferred
antiarrhythmic medication (AAM) in patients with left ventricular hypertrophy (LVH), due to …
antiarrhythmic medication (AAM) in patients with left ventricular hypertrophy (LVH), due to …
[HTML][HTML] Efficacy and safety of Shen-Song-Yang-Xin capsule for treating arrhythmia in the elderly patients with coronary heart disease: protocol for a systematic review …
Z Zeng, ZJ Zhuang, YX He, ZJ Yang, Y Song - Medicine, 2018 - journals.lww.com
Background: Coronary heart disease (CHD) is a major cause of mortality worldwide. Shen-
Song-Yang-Xin capsule (SSYXC) has received extensive attention as an alternative therapy …
Song-Yang-Xin capsule (SSYXC) has received extensive attention as an alternative therapy …
Efeitos bradicardicos e antiarritmicos do D-Limoneno em ratos
GA Nascimento, DS Souza, BS Lima… - Arquivos Brasileiros …, 2019 - SciELO Brasil
Resumo Fundamento: O D-limoneno (DL) é um monoterpeno e o principal componente do
óleo essencial de frutas cítricas. Ele apresenta atividades anti-hiperglicêmicas e …
óleo essencial de frutas cítricas. Ele apresenta atividades anti-hiperglicêmicas e …
New-onset atrial fibrillation following arteriovenous fistula increases adverse clinical events in dialysis patients with end-stage renal disease
W Song, L Wu, C Sun, X Kong, H Wang - Frontiers in Cardiovascular …, 2024 - frontiersin.org
Background End-stage renal disease (ESRD) patients have a high potential cardiovascular
burden, and cardiovascular disease (CVD) is the leading cause of death in maintenance …
burden, and cardiovascular disease (CVD) is the leading cause of death in maintenance …
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients
A AlTurki, R Proietti, V Russo, T Dhanjal… - Pharmacological …, 2019 - Elsevier
Implantable cardioverter-defibrillators (ICDs) have revolutionized the primary and secondary
prevention of patients with ventricular arrhythmias. However, the adverse effects of …
prevention of patients with ventricular arrhythmias. However, the adverse effects of …
[PDF][PDF] Wytyczne ESC 2022 dotyczące oceny ryzyka sercowo-naczyniowego i postępowania u pacjentów poddawanych operacjom niekardiochirurgicznym
S Halvorsen, J Mehilli, S Cassese… - Kardiologia Polska …, 2022 - journals.viamedica.pl
Treść tych wytycznych Europejskiego Towarzystwa Kardiologicznego (ESC) została
opublikowana tylko do użytku osobistego i edukacyjnego. Nie zezwala się na …
opublikowana tylko do użytku osobistego i edukacyjnego. Nie zezwala się na …
Role of medical management of cardiogenic shock in the era of mechanical circulatory support
In the absence of an evidence-based management approach to cardiogenic shock, clinical
guidelines are based on expert opinion and routine clinical practice patterns. Further studies …
guidelines are based on expert opinion and routine clinical practice patterns. Further studies …
Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA and ESC WG on Cardiovascular Pharmacology endorsed by HRS …
GA Dan, A Martinez-Rubio - Ep Europace, 2018 - academic.oup.com
I read with an interest consensus document of experts on antiarrhythmic drug therapy,
published in Europace on 1 May 2018. 1 With pleasure I noticed the tendency of …
published in Europace on 1 May 2018. 1 With pleasure I noticed the tendency of …